Total Payments
$19,128
2024 Payments
$678.24
Companies
42
Transactions
321
Medicare Patients
1,133
Medicare Billing
$65,991
Payment Breakdown by Category
Food & Beverage$16,701 (87.3%)
Other$2,400 (12.5%)
Education$27.12 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,701 | 316 | 87.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,400 | 1 | 12.5% |
| Education | $27.12 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,237 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,953 | 22 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $1,493 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,485 | 23 | $0 (2022) |
| Amgen Inc. | $1,347 | 36 | $0 (2021) |
| Gilead Sciences, Inc. | $1,001 | 11 | $0 (2024) |
| Medtronic Vascular, Inc. | $958.12 | 8 | $0 (2020) |
| PFIZER INC. | $770.51 | 24 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $663.17 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $569.24 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $678.24 | 6 | Gilead Sciences, Inc. ($230.59) |
| 2023 | $893.95 | 8 | Gilead Sciences, Inc. ($232.84) |
| 2022 | $4,169 | 18 | ABBVIE INC. ($2,743) |
| 2021 | $1,806 | 30 | Medtronic, Inc. ($307.94) |
| 2020 | $1,639 | 37 | Medtronic Vascular, Inc. ($294.89) |
| 2019 | $3,071 | 68 | Janssen Pharmaceuticals, Inc ($459.82) |
| 2018 | $3,098 | 63 | SANOFI-AVENTIS U.S. LLC ($578.79) |
| 2017 | $3,774 | 91 | SANOFI-AVENTIS U.S. LLC ($842.27) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $120.14 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $120.14 | General |
| 09/18/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $120.14 | General |
| Category: HCV | ||||||
| 05/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $110.45 | General |
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $82.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $124.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $89.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $114.71 | General |
| 08/16/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $127.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $90.46 | General |
| Category: Cardiovascular | ||||||
| 02/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $101.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/12/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $127.21 | General |
| Category: ANTIBIOTIC | ||||||
| 01/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $118.13 | General |
| 11/30/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: ANTIBIOTIC | ||||||
| 11/09/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $98.43 | General |
| 10/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $95.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/14/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $72.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/24/2022 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $81.29 | General |
| 08/17/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $93.01 | General |
| 08/10/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $112.71 | General |
| 06/29/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $84.96 | General |
| Category: Cardiovascular | ||||||
| 05/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $108.06 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 369 | 439 | $60,914 | $20,158 |
| 2020 | 13 | 764 | 1,155 | $135,334 | $45,834 |
Total Patients
1,133
Total Services
1,594
Medicare Billing
$65,991
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 84 | 96 | $32,928 | $10,491 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 40 | 40 | $4,453 | $4,520 | 101.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 68 | $17,340 | $4,273 | 24.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 139 | 189 | $2,835 | $567.00 | 20.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 45 | 46 | $3,358 | $305.75 | 9.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 169 | 323 | $82,365 | $21,289 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 91 | 91 | $10,068 | $10,116 | 100.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 30 | 34 | $11,662 | $3,800 | 32.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 53 | 53 | $3,445 | $3,233 | 93.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 33 | $5,643 | $1,247 | 22.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 170 | 381 | $5,715 | $1,134 | 19.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 11 | 15 | $3,255 | $1,058 | 32.5% |
| 77067 | Mammography of both breasts | Office | 2020 | 11 | 11 | $1,837 | $1,012 | 55.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 84 | 92 | $6,716 | $929.02 | 13.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 54 | 55 | $1,100 | $866.16 | 78.7% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 16 | 18 | $2,268 | $706.60 | 31.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 32 | 36 | $792.00 | $238.96 | 30.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 13 | 13 | $468.00 | $203.60 | 43.5% |
About Barry Kricsfeld, MD FACP
Barry Kricsfeld, MD FACP is a Internal Medicine healthcare provider based in Council Bluffs, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083668636.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Barry Kricsfeld, MD FACP has received a total of $19,128 in payments from pharmaceutical and medical device companies, with $678.24 received in 2024. These payments were reported across 321 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($16,701).
As a Medicare-enrolled provider, Kricsfeld has provided services to 1,133 Medicare beneficiaries, totaling 1,594 services with total Medicare billing of $65,991. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Council Bluffs, IA
- Active Since 05/19/2006
- Last Updated 08/15/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083668636
Products in Payments
- UBRELVY (Drug) $2,733
- FARXIGA (Drug) $1,000
- XARELTO (Drug) $857.15
- ELIQUIS (Drug) $755.54
- INVOKANA (Drug) $629.49
- SOLIQUA (Drug) $514.73
- Prolia (Biological) $508.78
- DIABETES - DISEASE (Drug) $468.48
- ENTRESTO (Drug) $467.89
- Reveal LINQ (Device) $435.83
- TRULICITY (Drug) $381.26
- Epclusa (Drug) $354.54
- Repatha (Biological) $329.55
- TOUJEO (Drug) $317.23
- Vascepa (Drug) $302.80
- PRALUENT (Drug) $289.95
- NUEDEXTA (Drug) $267.83
- Aimovig (Biological) $266.62
- QULIPTA (Drug) $252.56
- NUZYRA (Drug) $252.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Council Bluffs
Alan Kricsfeld, Md, MD
Internal Medicine — Payments: $68,678
Internal Medicine $68,678
Diana Rabadi-Marar, M.d, M.D
Internal Medicine — Payments: $37,016
Internal Medicine $37,016
Matthew Fryzek, M.d, M.D
Internal Medicine — Payments: $35,526
Internal Medicine $35,526
Isam Marar, M.d, M.D
Internal Medicine — Payments: $30,637
Internal Medicine $30,637
Jeremy Pepin, M.d, M.D
Internal Medicine — Payments: $20,958
Internal Medicine $20,958
Dr. Vikrant Salaria, M.d, M.D
Internal Medicine — Payments: $7,994
Internal Medicine $7,994